LOGIN
Three doses of 15mg/kg IV TXA reduces blood loss vs. placebo in trochanteric fracture surgery
May 2019
Three doses of 15mg/kg IV TXA reduces blood loss vs. placebo in trochanteric fracture surgery
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A
Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial
Hong Kong Med J. 2019 Apr;25(2):120-126.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
176 patients with trochanteric fractures and scheduled for surgical treatment were randomized to receive 3 doses of intravenous tranexamic acid or placebo (normal saline). Outcomes of interest included peri-operative, obivous and hidden blood loss, post-operative hemoglobin levels, proportion of patients who received red blood cell transfusion, number of transfused red blood cell units per person,...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.